Next Science
Hospitals and Health CareFlorida, United States51-200 Employees
Next Science Limited is a medical technology company focused on advancing wound healing and reducing biofilm-related infections. Headquartered in Sydney, Australia, it also operates commercially in Florida, United States, serving healthcare providers with its products and education initiatives. The company grew from a concern about avoidable amputations linked to infected wounds and seeks to improve patient outcomes by supporting clinicians with evidence-based solutions. Within the Hospitals and Health Care sector, it positions itself through product development and clinical education aimed at advancing healing and informing clinical practice. In 2023, it announced findings from a pilot knee study using its Xbio suite to reduce postoperative biofilm infections. Earlier collaborations in Australia expanded access to its BlastX antimicrobial biofilm wound gel through pharmacy networks, including arrangements with Oraderm and Arrotex Pharmaceuticals Pty Ltd and TerryWhite Chemmart pharmacies.
1-888-653-2347 
support@leadiq.com 
